4//SEC Filing
Arno Therapeutics, Inc 4
Accession 0000914190-16-000610
CIK 0001195116operating
Filed
Apr 10, 8:00 PM ET
Accepted
Apr 11, 4:20 PM ET
Size
17.1 KB
Accession
0000914190-16-000610
Insider Transaction Report
Form 4
Zukiwski Alexander A
VP & Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2016-04-07+1,196,070→ 1,196,070 totalExercise: $0.37Exp: 2026-04-07→ Common Stock (1,196,070 underlying)
Holdings
- 55,736
Stock Option (right to buy)
Exercise: $2.40Exp: 2021-06-22→ Common Stock (55,736 underlying) - 12,187
Stock Option (right to buy)
Exercise: $2.40Exp: 2023-01-14→ Common Stock (12,187 underlying) - 109,375
Stock Option (right to buy)
Exercise: $2.40Exp: 2021-06-22→ Common Stock (109,375 underlying) - 36,562
Stock Option (right to buy)
Exercise: $2.40Exp: 2023-01-14→ Common Stock (36,562 underlying) - 316,389
Stock Option (right to buy)
Exercise: $2.40Exp: 2023-11-04→ Common Stock (316,389 underlying) - 183,822
2012 Series A Warrants (right to buy)
Exercise: $1.36From: 2012-11-26Exp: 2017-11-26→ Common Stock (183,822 underlying) - 261,832
Common Stock
- 711,301
Stock Option (right to buy)
Exercise: $2.90Exp: 2024-01-24→ Common Stock (711,301 underlying) - 77,880
2013 Series D Warrants (right to buy)
Exercise: $2.14From: 2013-10-29Exp: 2018-10-29→ Common Stock (77,880 underlying)
Footnotes (4)
- [F1]Currently exercisable.
- [F2]Vests in equal 36-monthly installments commencing 12/4/13.
- [F3]Vests 25% on first anniversary date and thereafter will vest in 24 equal monthly installments.
- [F4]Vests one-third on the first anniversary of grant and thereafter in 24 equal monthly installments.
Documents
Issuer
Arno Therapeutics, Inc
CIK 0001195116
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001195116
Filing Metadata
- Form type
- 4
- Filed
- Apr 10, 8:00 PM ET
- Accepted
- Apr 11, 4:20 PM ET
- Size
- 17.1 KB